Halaman 2 - Imunoterapi untuk kanker paru-paru Dokter Terbaik - TOP-44 dokter

Profesor Cemil Bilir memiliki lebih dari 12 tahun pengalaman spesialisasi dalam imunoterapi kanker paru-paru di Rumah Sakit VM Medical Park Pendik.

• Bersertifikasi dewan dalam onkologi medis dengan pelatihan tambahan di Cleveland Clinic
• Anggota aktif ASCO dan ESMO – selalu mengikuti protokol terbaru
• Saat ini sedang menempuh program Ph.D. dalam kimia anorganik untuk meningkatkan pendekatan pengobatan
• Mengajar onkologi medis di Fakultas Kedokteran Universitas Sakarya

Prof. Madya Nail Paksoy berspesialisasi dalam imunoterapi untuk kanker paru di Rumah Sakit Medipol Bahçelievler, dengan pengalaman penelitian dan uji klinis yang luas.

• Bersertifikasi Dewan ESMO dalam Onkologi Medis
• Subinvestigator dalam berbagai uji klinis imunoterapi kanker paru internasional
• Penelitian yang diterbitkan tentang pengobatan baru untuk NSCLC
• Pelatihan Fellowship dalam Onkologi Medis di Universitas Istanbul

Berspesialisasi dalam imunoterapi untuk kanker paru-paru di Kompleks Rumah Sakit Medical Park Antalya – dilatih di Universitas Akdeniz, pemimpin dalam onkologi.

• Bersertifikat dewan dalam onkologi medis dengan 7+ tahun pengalaman
• Pelatihan ekstensif di Universitas Akdeniz, sekolah kedokteran terkemuka Turki
• Bekerja dengan protokol imunoterapi canggih untuk kanker paru-paru
• Anggota Asosiasi Onkologi Medis Turki

Dr. Ozden berspesialisasi dalam onkologi medis dengan pelatihan ekstensif dalam imunoterapi untuk kanker paru-paru di Universitas Kocaeli.

• Lebih dari 20 tahun pengalaman dalam penyakit dalam dan onkologi
• Menyelesaikan subspesialisasi onkologi medis di Universitas Kocaeli
• Lulus dari Fakultas Kedokteran Cerrahpaşa yang bergengsi dari Universitas Istanbul
• Berpraktik di Rumah Sakit VM Medical Park Pendik

Pakar terkemuka dalam imunoterapi untuk kanker paru-paru – Dr. Felip mengintegrasikan imunoterapi novel ke dalam protokol pengobatan di Hospital Quiron Barcelona.

• Anggota aktif ESMO, ASCO, dan IASLC
• Menerima Penghargaan ESMO Women for Oncology pada tahun 2015
• Wakil Ketua Kongres WCLC ke-20 di Barcelona
• Profesor Kedokteran di Universitat de Vic

Profesor Onkologi Medis di Universitas Trakya – berspesialisasi dalam imunoterapi untuk kanker paru-paru di Rumah Sakit Liv Universitas İstinye Topkapı.

• Pengalaman 20+ tahun dalam onkologi medis
• Lulusan pelatihan sub-spesialisasi (fellowship) dalam Onkologi Medis dari Universitas Trakya
• Mantan Lektor Kepala dan saat ini Profesor di Universitas Trakya
• Pengalaman dinas militer di Rumah Sakit Komando Angkatan Udara Turki

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Prof. Madya Atakan Topcu berspesialisasi dalam imunoterapi untuk kanker paru-paru di Rumah Sakit Distrik Medipol Acibadem, dengan lebih dari 50 artikel ilmiah yang telah diterbitkan.

• Ahli dalam terapi target dan imunoterapi untuk tumor padat
• Anggota European Society for Medical Oncology (ESMO)
• Mendapatkan pelatihan Fellowship dalam Onkologi Medis di Universitas Bezmialem Vakıf
• Anggota Dewan Redaksi jurnal BMC Cancer

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Profesor Madya Onkologi Medis di Universitas İstinye Liv Hospital Topkapı – berspesialisasi dalam imunoterapi kanker paru-paru dengan penelitian yang diterbitkan di jurnal berpeninjauan sejawat.

• Anggota American Society of Clinical Oncology (ASCO) sejak 2018
• Telah menerbitkan banyak studi tentang hasil pengobatan kanker paru-paru
• Koordinator Pendidikan untuk Sub-cabang Onkologi Medis
• Program Residen Ilmu Penyakit Dalam di Pusat Aplikasi dan Penelitian Kesehatan Istanbul Şişli Hamidiye Etfal

Dr. Raj Nagarkar telah melakukan 50.000+ operasi kanker – 19 tahun keahlian onkologi bedah yang berfokus pada onkologi toraks.

• Terlatih di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Terlibat dalam 200+ uji klinis imunoterapi
• Profesor untuk DNB Superspecialty Surgical Oncology
• Penulis berbagai publikasi internasional dan nasional

Dr. Shaunak berspesialisasi dalam imunoterapi untuk kanker paru-paru, dengan fokus kuat pada perawatan berbasis molekuler dan terapi target.

• Terlatih dalam Onkologi Medis di Rumah Sakit Indraprastha Apollo
• Mempresentasikan penelitian tentang kanker lambung di simposium ASCO
• Keahlian dalam dasar molekuler kanker
• Residensi Senior di Penyakit Dalam

Berspesialisasi dalam bedah kanker invasif minimal dengan hasil yang sangat baik – Dr. Banswal telah berhasil melakukan lebih dari 10.000 operasi besar.

• 10 tahun pengalaman onkologi bedah
• Terlatih dalam kanker gastrointestinal di Tata Medical Centre
• Asisten Profesor di State Cancer Institute
• Berbagai publikasi nasional dan internasional